May 15, 2024 03:23 PM EDT

Eli Lilly settles with medical spa over its marketing of compounded tirzepatide

Nicole DeFeudis

Editor

Eli Lilly reached a settlement with a South Carolina medical spa, marking a win in a broader legal campaign against how compounders have marketed versions …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Eli Lilly settles with medical spa over its marketing of compounded tirzepatide

Nicole DeFeudis

Editor

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote

Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston

BridgeBio sticks to script for ATTR-CM as Alnylam cleans up ‘typo’ snafu

Roche's Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed

Lilly inks obesity deal with seed-stage RNA startup as its genetic medicines effort enters the spotlight

How to secure full enrollment and a 30x ROI: A conversation with the CEO of the boutique enrollment agency doing just ...

Eli Lil­ly set­tles with med­ical spa over its mar­ket­ing of com­pound­ed tirzepatide

Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Eli Lilly settles with medical spa over its marketing of compounded tirzepatide